SEP 10, 2026 · OBSERVATIONAL STUDY
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Participants
ClinicalTrials.gov
This is a planned observational cohort study with no results reported; it describes a real-world registry design but carries no outcome data, efficacy estimates, or safety findings yet.
Reported
Planned enrollment1000
Study duration (primary outcome a…Approximately 3 years
Primary outcome 1Real-world Response Rate (rwRR)